Xenomics

Exponential Genomics Inc. (Xenomics) has built a team of scientists trained at Harvard and MIT that utilize genetically modified microorganisms to manufacture compounds identical to those found in nature. The core technology is a novel gene-editing technique capable of performing over 400 years of CRISPR in 8 weeks. Current commercialization projects include streamlining the manufacturing of biopharmaceuticals, vaccines, breastmilk, cell therapies, cultured meats & dairy, water desalination, cannabinoid nutraceuticals, pharma-psychedelics, food flavors, and perfume scents.